Patents by Inventor Elizabeth J. C. Mellor

Elizabeth J. C. Mellor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusion proteins and particles
    Patent number: 5463024
    Abstract: Fusion proteins comprise a first amino acid sequence and a second amino acid sequence. The first amino acid sequence is derived from a retrotransposon or an RNA retrovirus and confers on the fusion protein the ability to assemble into particles; an example is the product of the TYA gene of the yeast retrotransposon Ty. The second amino acid sequence is biologically active; for example it may be antigenic. So particles formed of the fusion proteins may be useful in vaccines or in diagnostic or purification applications.
    Type: Grant
    Filed: September 1, 1993
    Date of Patent: October 31, 1995
    Assignee: British Biotech Pharmaceuticals Limited
    Inventors: Alan J. Kingsman, Susan M. Kingsman, Sally E. Adams, Elizabeth J. C. Mellor, Michael H. Malim
  • Fusion proteins and particles
    Patent number: 5008373
    Abstract: Fusion proteins comprise a first amino acid sequence and a second amino acid sequence. The first amino acid sequence is derived from a retrotransposon or an RNA retrovirus and confers on the fusion protein the ability of assemble into particles; an example is the product of the TYA gene of the yeast retrotransposon Ty. The second amino acid sequence is biologically active; for example, it may be antigenic.
    Type: Grant
    Filed: October 26, 1987
    Date of Patent: April 16, 1991
    Assignee: Oxford Gene Systems Limited
    Inventors: Alan J. Kingsman, Susan M. Kingsman, Sally E. Adams, Elizabeth J. C. Mellor, Michael H. Malim